Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

If you’ve been suffering from a chronic or recurrent infection, you’re not alone. If it happens to be a urinary tract infection (UTI), the numbers may surprise you. It’s estimated that 150 million UTIs occur annually worldwide, accounting for more than $6 billion in healthcare costs.

We’re sharing a very personal story of one woman who has suffered from UTIs for much of her life. Now, about 45 years later, Raylene Billerbeck has finally found some relief.

MicroGenDX’s Next Generation DNA Sequencing delivers precise data for the diagnosis of infections with accurate microbial identification. Compared to traditional culture labs, Next Generation Sequencing (NGS) identifies 100 percent of the microbes within a sample with 99.9 percent accuracy. Plus, NGS detects antibiotic resistance genes for eight antibiotic classes, and delivers an antibiotic recommendations sheet.

Stay tuned to hear how MicroGenDX’s innovative testing technique has transformed Raylene’s life, and how NGS is shaking up the medical industry.

Clinical trials are an opportunity for patients to receive promising new therapies, but they can be difficult to navigate. Learn how The Leukemia & Lymphoma Society’s Clinical Trial Support Center is helping guide patients.

There are approximately 7,000 known rare diseases, but only 5% of them have an approved treatment. Learn how early intervention, proper management strategies, and clinical trials are key for rare disease patients. 

Friedreich’s Ataxia is a progressive and debilitating neurological disorder. It's important to recognize symptoms and obtain an early diagnosis to properly manage the condition.

Comments

comments